StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 2/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.36MP/E –Yield –

CannaPharmaRx total assets

Total assets on the balance sheet at the end of each period.

CannaPharmaRx's total assets was $6.89M at Jun 30, 2026. For fiscal 2025 it was $7.02M, down 35.2% from the year before. Over ten years it grew 89.0% a year on average. The highest annual figure on record is $16.02M in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.02M-35.2%
FY2024Dec 31, 2024$10.84M-7.7%
FY2023Dec 31, 2023$11.75M+85.3%
FY2022Dec 31, 2022$6.34M+5442.8%
FY2021Dec 31, 2021$114.33K-98.7%
FY2020Dec 31, 2020$8.75M-45.4%
FY2019Dec 31, 2019$16.02M+58.6%
FY2018Dec 31, 2018$10.10M–
FY2017Dec 31, 2017$0-100.0%
FY2016Dec 31, 2016$1.67K-86.2%
FY2015Dec 31, 2015$12.06K-99.3%
FY2014Dec 31, 2014$1.80M+7188068.0%
FY2012Dec 31, 2012$250.0%
FY2011Dec 31, 2011$25-75.0%
FY2010Dec 31, 2010$100–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.89M-39.9%
Q1 FY2026Mar 31, 2026$6.58M-41.4%
Q4 FY2025Dec 31, 2025$7.02M-35.2%
Q3 FY2025Sep 30, 2025$11.62M-0.6%
Q2 FY2025Jun 30, 2025$11.47M-2.1%
Q1 FY2025Mar 31, 2025$11.23M-1.2%
Q4 FY2024Dec 31, 2024$10.84M-7.7%
Q3 FY2024Sep 30, 2024$11.68M+126.6%
Q2 FY2024Jun 30, 2024$11.71M+120.1%
Q1 FY2024Mar 31, 2024$11.37M+115.6%
Q4 FY2023Dec 31, 2023$11.75M+85.3%
Q3 FY2023Sep 30, 2023$5.16M-4.9%
Q2 FY2023Jun 30, 2023$5.32M-7.6%
Q1 FY2023Mar 31, 2023$5.27M-10.9%
Q4 FY2022Dec 31, 2022$6.34M+5442.8%
Q3 FY2022Sep 30, 2022$5.42M-23.0%
Q2 FY2022Jun 30, 2022$5.76M-34.9%
Q1 FY2022Mar 31, 2022$5.91M-32.7%
Q4 FY2021Dec 31, 2021$114.33K-98.7%
Q3 FY2021Sep 30, 2021$7.04M-57.2%
Q2 FY2021Jun 30, 2021$8.85M-44.8%
Q1 FY2021Mar 31, 2021$8.79M-34.0%
Q4 FY2020Dec 31, 2020$8.75M-45.4%
Q3 FY2020Sep 30, 2020$16.45M-26.8%
Q2 FY2020Jun 30, 2020$16.04M-23.7%
Q1 FY2020Mar 31, 2020$13.32M-36.7%
Q4 FY2019Dec 31, 2019$16.02M+58.6%
Q3 FY2019Sep 30, 2019$22.47M+2861.2%
Q2 FY2019Jun 30, 2019$21.01M+94491.9%
Q1 FY2019Mar 31, 2019$21.04M–
Q4 FY2018Dec 31, 2018$10.10M–
Q3 FY2018Sep 30, 2018$758.76K–
Q2 FY2018Jun 30, 2018$22.22K–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0-100.0%
Q3 FY2017Sep 30, 2017$0-100.0%
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$1.67K–
Q3 FY2016Sep 30, 2016$4.17K–

More CannaPharmaRx figures

See a number that looks wrong?